Manufacturer of Aspexia Acne Treatment Cream Agrees to Halt Production of Product Under Amended Consent Decree



DOCUMENTS
  • Consent Decree


SACRAMENTO, Calif. –– A manufacturer of an acne treatment cream that allegedly degrades to benzene when exposed to normal and expected temperatures has agreed to stop producing the product under a recent amended consent decree filed in a California federal court.

The plaintiffs and defendant filed the amended consent decree on Oct. 30 in the U.S. District Court for the Eastern District of California.

The plaintiff filed the underlying class action against Genomma Lab USA Inc. in March 2024, contending that the defendant had designed, manufactured, marketed, and sold acne treatment products formulated with benzoyl peroxide. The plaintiffs alleged in …






UPCOMING CONFERENCES




HarrisMartin’s Artificial Stone Silicosis Epidemic Litigation Conference

January 10, 2025 - Long Beach, CA
The Westin Long Beach

MORE DETAILS



HarrisMartin's MDL Conference

December 04, 2024 - New York, NY
Virgin Hotels NYC

MORE DETAILS